Publications

Phase Iii Trial Comparing 4-Day Chronomodulated Therapy Versus 2-Day Conventional Delivery of Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Chemotherapy of Metastatic Colorectal Cancer: The European Organisation for Research and Treatment of Cancer Chronotherapy Group

AuthID
P-004-J6C

Author(s)

Giacchetti, S

Bjarnason, G

Iacobelli, S

Focan, C

Coudert, B

Humblet, Y

Canon, JL

Adenis, A

Lo Re, G

Carvalho, C

Schueller, J

Anciaux, N

Lentz, MA

Baron, B

Gorlia, T

Levi, F

Document Type

Article

Year published

2006

Published

in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X

Volume: 24, Issue: 22, Pages: 3562-3569 (8)

Indexing

Wos^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1200/jco.200.06.1440

Pubmed: 16877722

Wos: WOS:000239443400010

Source Identifiers

ISSN: 0732-183X

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Phase Iii Trial Comparing 4-Day Chronomodulated Therapy Versus 2-Day Conventional Delivery of Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Chemotherapy of Metastatic Colorectal Cancer: The European Organisation for Research and Treatment of Cancer Chronotherapy Group

Useful Links

Get Help

Federated Authentication (Click on the image)

Phase Iii Trial Comparing 4-Day Chronomodulated Therapy Versus 2-Day Conventional Delivery of Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Chemotherapy of Metastatic Colorectal Cancer: The European Organisation for Research and Treatment of Cancer Chronotherapy Group

Useful Links

Get Help